ConductScience.org, home

Paper20043028

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.

Jackson AL and 1 other. Nat Rev Drug Discov, 2010. Cited by 859 papers, by iCite.

Cite this record

ConductScience Library. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Papers, record 20043028. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20043028

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.
PubMed
Journal
Nat Rev Drug Discov
PubMed
Year
2010
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
859
iCite
Relative citation ratio, by iCite
19.2
iCite
Revised in PubMed
2024-01-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jackson ALAimee L
2Linsley PSPeter S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene SilencingMajor topic
Gene TargetingMajor topic
RNA, Small InterferingMajor topic
Animals
Clinical Trials as Topic
Genetic Therapy
Humans
MicroRNAs

Source PubMed

Download CSV of topics

References114

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114668052Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells.J Drug Target2003https://conductscience.org/library/papers/14668052PubMed
217652171Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17652171PubMed
315735639Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.Nature2005https://conductscience.org/library/papers/15735639PubMed
416091630siRNA-mediated off-target gene silencing triggered by a 7 nt complementation.Nucleic Acids Res2005https://conductscience.org/library/papers/16091630PubMed
515806104Combinatorial microRNA target predictions.Nat Genet2005https://conductscience.org/library/papers/15806104PubMed
612554881Sequence requirements for micro RNA processing and function in human cells.RNA2003https://conductscience.org/library/papers/12554881PubMed
715813981Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo.J Inflamm (Lond)2004https://conductscience.org/library/papers/15813981PubMed
818155315Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides.Adv Drug Deliv Rev2008https://conductscience.org/library/papers/18155315PubMed
916111635Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.Immunity2005https://conductscience.org/library/papers/16111635PubMed
1015685193Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.Nature2005https://conductscience.org/library/papers/15685193PubMed
1119239886Origins and Mechanisms of miRNAs and siRNAs.Cell2009https://conductscience.org/library/papers/19239886PubMed
1211157775RNA interference is mediated by 21- and 22-nucleotide RNAs.Genes Dev2001https://conductscience.org/library/papers/11157775PubMed
13175795742'-O-methyl-modified RNAs act as TLR7 antagonists.Mol Ther2007https://conductscience.org/library/papers/17579574PubMed
1410749213An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.Nature2000https://conductscience.org/library/papers/10749213PubMed
1515695330RNA interference rescue by bacterial artificial chromosome transgenesis in mammalian tissue culture cells.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15695330PubMed
1612198168MicroRNA maturation: stepwise processing and subcellular localization.EMBO J2002https://conductscience.org/library/papers/12198168PubMed
1712672692The microRNAs of Caenorhabditis elegans.Genes Dev2003https://conductscience.org/library/papers/12672692PubMed
1812789138Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.Mol Vis2003https://conductscience.org/library/papers/12789138PubMed
1916308212Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type.J Drug Target2005https://conductscience.org/library/papers/16308212PubMed
2010617568Targeted mRNA degradation by double-stranded RNA in vitro.Genes Dev1999https://conductscience.org/library/papers/10617568PubMed

See all 114 referencesDownload CSV of references

Cited by551

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 859 citations.

PMIDTitleJournalYearIn PapersSource
42984764Inducible and reversible in vivo protein degradation reveals T cell-intrinsic regulatory function of SHP-1.Front Immunol2026https://conductscience.org/library/papers/42984764PubMed
42964787Controlling the controls: On the importance of validated negative control ASOs.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42964787PubMed
42911498Cas13d-Mediated Knockdown of Long Noncoding RNAs.Methods Mol Biol2027https://conductscience.org/library/papers/42911498PubMed
42886793Programmable and selective silencing of oncogenic fusion transcripts by CRISPR-Cas13b via breakpoint sequence recognition.Sci Adv2026https://conductscience.org/library/papers/42886793PubMed
42846378Host-directed therapeutics against antimicrobial-resistant bacterial infections: emerging roles of multi-omics and systems biology.Front Pharmacol2026https://conductscience.org/library/papers/42846378PubMed
42729488From RNA design to delivery: Computational strategies for functional RNA therapeutics.Bioact Mater2027https://conductscience.org/library/papers/42729488PubMed
42688902Generation of spCAS9 expressing human mesenchymal stem cell line to study gene function during osteoblast differentiation.JBMR Plus2026https://conductscience.org/library/papers/42688902PubMed
42650879p21 (CDKN1A) Is the Major Driver of Sulforaphane-Mediated Reduction in SAMHD1 T592 Phosphorylation in Macrophages.Biomolecules2026https://conductscience.org/library/papers/42650879PubMed
42608568LncRNA SNHG14 drives alveolar inflammation in bronchopulmonary dysplasia via DNMT3a-mediated epigenetic silencing of miR-214-3p.Inflamm Res2026https://conductscience.org/library/papers/42608568PubMed
42597608Design and development of lipid nanoparticle formulations for brain gene therapy.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42597608PubMed
42439627CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells.Cells2026https://conductscience.org/library/papers/42439627PubMed
42382979Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics.Antib Ther2026https://conductscience.org/library/papers/42382979PubMed
42367245Understanding the biological limits of hybridization-dependent siRNA off-target interactions.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42367245PubMed
42360639The Diagnostic and Therapeutic Value of Micro-RNA in Parkinson's Disease.Cell Mol Neurobiol2026https://conductscience.org/library/papers/42360639PubMed
42282505Unveiling the Silent Regulators: Noncoding RNAs in Parasitic Disease Diagnosis and Therapy.J Parasitol Res2026https://conductscience.org/library/papers/42282505PubMed
42200443Hsp70 is phosphorylated in a conserved response to DNA damage and contributes to cell cycle control.Elife2026https://conductscience.org/library/papers/42200443PubMed
42198287Evolution of siRNA Therapeutics: From Mechanistic Foundations to Clinical Expansion.Pharmaceutics2026https://conductscience.org/library/papers/42198287PubMed
42040413Molecular Dynamics Simulation-Assisted siRNA Design for Dual-Ubiquitinated SKP2 Silencing via Ago2 Anchoring in Breast Cancer.ACS Omega2026https://conductscience.org/library/papers/42040413PubMed
41984920Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells.PLoS One2026https://conductscience.org/library/papers/41984920PubMed
41959736Molecular mastery: Harnessing DNA technology for disease prevention.Genes Dis2026https://conductscience.org/library/papers/41959736PubMed

See all 551 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20043028

GET https://conductscience.org/api/papers/v1/20043028/references?page=2